Cubist Systematic Strategies’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1611 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1686 |
|
|
2024
Q1 | – | Sell |
-33,195
| Closed | -$2.08M | – | 2341 |
|
|
2023
Q4 | $2.08M | Buy |
+33,195
| New | +$2.08M | 0.01% | 802 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2091 |
|
|
2023
Q2 | – | Sell |
-10,736
| Closed | -$486K | – | 2412 |
|
|
2023
Q1 | $486K | Sell |
10,736
-157,691
| -94% | -$7.13M | ﹤0.01% | 1822 |
|
|
2022
Q4 | $6.85M | Buy |
168,427
+158,738
| +1,638% | +$6.45M | 0.04% | 500 |
|
|
2022
Q3 | $633K | Sell |
9,689
-30,803
| -76% | -$2.01M | ﹤0.01% | 2362 |
|
|
2022
Q2 | $2.46M | Buy |
40,492
+9,441
| +30% | +$574K | 0.02% | 1400 |
|
|
2022
Q1 | $1.95M | Buy |
31,051
+1,265
| +4% | +$79.4K | 0.02% | 1499 |
|
|
2021
Q4 | $2.26M | Buy |
29,786
+23,689
| +389% | +$1.8M | 0.02% | 1255 |
|
|
2021
Q3 | $682K | Sell |
6,097
-7,330
| -55% | -$820K | 0.01% | 1813 |
|
|
2021
Q2 | $2.17M | Buy |
13,427
+9,367
| +231% | +$1.52M | 0.02% | 1027 |
|
|
2021
Q1 | $495K | Sell |
4,060
-44,278
| -92% | -$5.4M | 0.01% | 1966 |
|
|
2020
Q4 | $7.4M | Buy |
48,338
+7,301
| +18% | +$1.12M | 0.1% | 263 |
|
|
2020
Q3 | $3.43M | Buy |
41,037
+28,777
| +235% | +$2.41M | 0.05% | 589 |
|
|
2020
Q2 | $901K | Sell |
12,260
-1,310
| -10% | -$96.3K | 0.02% | 1242 |
|
|
2020
Q1 | $576K | Sell |
13,570
-33,570
| -71% | -$1.42M | 0.02% | 1165 |
|
|
2019
Q4 | $2.87M | Buy |
47,140
+41,040
| +673% | +$2.5M | 0.05% | 556 |
|
|
2019
Q3 | $250K | Sell |
6,100
-1,050
| -15% | -$43K | 0.01% | 1650 |
|
|
2019
Q2 | $337K | Buy |
7,150
+4,767
| +200% | +$225K | 0.01% | 1719 |
|
|
2019
Q1 | $85K | Sell |
2,383
-37,167
| -94% | -$1.33M | ﹤0.01% | 2026 |
|
|
2018
Q4 | $1.13M | Buy |
39,550
+34,465
| +678% | +$985K | 0.05% | 506 |
|
|
2018
Q3 | $226K | Buy |
+5,085
| New | +$226K | 0.01% | 1334 |
|